Document is current

Article History

Received: 28 September 2021

Accepted: 20 June 2022

First Online: 16 August 2022

Competing interests

: N.C.T. has been a consultant or advisor for Pfizer Inc; and has received research funding from Pfizer Inc, Eli Lilly, and Novartis. S.L. has received research funding from Merck, Novartis, Roche, and Genentech. F.A. has received research funding from AstraZeneca, Novartis, Pfizer Inc, Eli Lilly, and Daiichi Sankyo, and served as a speaker/advisor for AstraZeneca, Novartis, Pfizer Inc, Eli Lilly, and Daiichi Sankyo (compensated to his institution). M.M. has received research grants from Roche and Novartis and speakers honoraria from AstraZeneca, Amgen, Roche/Genentech, Novartis, PharmaMar, Eli Lilly, and Pfizer Inc. V.D., has received consulting fees from Genentech, Pfizer Inc, AbbVie, Novartis Pharma KK, Roche-Peru, Eli Lilly, AstraZeneca, and Daiichi and serves on speakers bureaus for Pfizer Inc, Novartis Pharma KK, Roche-Peru, and AstraZeneca. K.A.G. has received consulting/advisory fees from Pfizer Inc, Novartis, AstraZeneca, Roche, Eli Lilly, Mylan, Bristol-Myers Squibb, NanoString Technologies, and Merck. N.H., has been a consultant or advisor for Eli Lilly, Novartis, and Pfizer Inc. H.S.R. has received research grant/funding from Pfizer Inc, Merck, Novartis, Lilly, Genentech, Odonate, Daiichi, Seattle Genetics, Eisai, Macrogenics, Sermonix, Boehringer Ingelheim, Polyphor, AstraZeneca, and Immunomedics; and has received honoraria from PUMA, Samsung, and Mylan. S.L. reports research fees and to her institution from AbbVie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Celgene, Cepheid, Eirgenix, GlaxoSmithKline, Immunomedics, Eli Lilly, Merck/MSD, Merck Kg, Novartis, Pfizer Inc, Pierre-Fabre, Puma, Roche, Samsung, Teva, and Vifor. M.C. has received consulting fees from Novartis, Merus, CytoDyn, Sermonix, and G1 Therapeutics; honoraria from Pfizer Inc; and research funding from Pfizer Inc, Novartis, Merus, Lilly, and G1 Therapeutics. R.S. F. has received consulting fees from Pfizer Inc, AstraZeneca, Bayer, Novartis, Bristol-Myers Squibb, Eisai, Eli Lilly, Merck, and Roche, as well as other research funding from Pfizer Inc and honoraria from Bayer, Pfizer Inc, Bristol-Myers Squibb, Novartis, Eisai, and Eli Lilly. Z.Z., C.Z., J.Q.C., Z.Y., D.R.L., P.W., T.L.V., P.A.R., X.H. and Y.L. are or were employees of and own stock in Pfizer Inc.